Navigation Links
Flavonoids In Orange Juice Make It A Healthy Drink, Despite The Sugar

from the fructose, orange juice or water group.

"We were intrigued by the fact that there was no increase in ROS or inflammation following orange juice consumption, even though its glucose concentration was the same as in participants in the glucose group," said Dandona. "This raised the question of what in the juice was responsible for suppressing ROS generation: flavonoids and vitamin C or fructose?"

An additional round of test on the samples showed that neither fructose nor vitamin C suppressed the oxygen free radicals. However the two types of flavonoids in orange juice -- hesperetin and naringenin -- inhibited ROS generation by 52 percent and 77 percent, respectively.

"Our data are relevant to patients with diabetes," said Dandona, "because stress from ROS and inflammation are increased significantly in this population and may contribute to development of atherosclerosis. Clearly the choice of foods that either don't increase or actually decrease oxidative and inflammatory stress is important.

"The search for safe non-inflammatory foods and diets must continue," Dandona stressed, "especially since obesity, being overweight and type 2 diabetes are associated with oxidative stress and inflammation, and more than 60 percent of U.S. population is affected by these conditions."


'"/>




Page: 1 2

Related medicine news :

1. Foods Rich In Flavonoids Effective In Prevention Of Cough
2. Science Stacks Up for Flavonoids for Heart Health
3. A Glass of Orange Juice To Keep Recurrence Of Kidney Stones At Bay
4. Eating Live Crabs Infects 8 In Orange County
5. Mandarin Oranges Reduce Liver Cancer Risk
6. Pass the Orange Tomato Sauce Please
7. An Orange a Day may Keep Heart Disease Away
8. Veterans Exposed to Agent Orange Increased Risk of Prostate Cancer Recurrence
9. Juices are Best! but which one?
10. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
11. Pomegranate Juice Is Helpful In Arresting Osteoarthritis
Post Your Comments:
(Date:12/15/2009)... will they get paid for patient care? Capture,s medical billing ... ... Washington, DC (Vocus) December 15, 2009 ... These codes are what healthcare providers submit to Medicare ... consultation, whether in a provider’s office or hospital setting. Healthcare ...
(Date:12/15/2009)... named 4th Best Staffing Firm to Work For. , ... ... has named LocumTenens.com, a leading provider of temporary physician and CRNA ... their inaugural 2009 list., , , , ,“We are proud to ... care about investing in our associates,” said R. Shane Jackson president ...
(Date:12/15/2009)... out-of-pocket costs for beneficiaries based on health status categories and ... ... Antonio, TX (Vocus) Dec. 14, 2009 -- Physicians Health Choice ... recognized for cost-sharing effectiveness and value in the design of ... Medicare beneficiaries. The Medicare Advantage company won for its ...
(Date:12/15/2009)... most caring, conscientious practice you have ever been a part of. ... Dallas, we can help to achieve this goal and meet your ... ... -- The Dermatology Center of Dallas, a Dallas based, full-service medical ... “J.B.” Foshee, MD in their practice. Dr. Foshee joins James ...
(Date:12/15/2009)... - 2009 Industry trend Continues as Henry Ford Health System ... (SaaS) provider- , ... Hazlet, ... provider of Software-as-a-Service (SaaS) talent acquisition solutions , announced ... iCIMS Talent Platform to support its talent management needs. ...
Breaking Medicine News(10 mins):Health News:Medicare Eliminates Consultation Codes for Doctors 2Health News:LocumTenens.com Named 4th Best Staffing Firm to Work For 2Health News:Physicians Health Choice Receives Senior Choice Gold Award for 2010 Medicare Plan Benefits 2Health News:Physicians Health Choice Receives Senior Choice Gold Award for 2010 Medicare Plan Benefits 3Health News:Physicians Health Choice Receives Senior Choice Gold Award for 2010 Medicare Plan Benefits 4Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems 2Health News:iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems 3Health News:iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems 4
... hospitals associated with Fox Chase Cancer Center in ... academic cancer center, where most new treatment protocols ... is provided, is a highly effective model for ... , Fox Chase, an NCI-designated Comprehensive ...
... - Celecoxib, the anti-inflammatory medication also known by the ... reduces a specific proliferation measurement of precancerous lesions in ... of Texas M. D. Anderson Cancer Center. This finding ... cancer in individuals at higher risk of developing the ...
... 15 JumpStart Inc., the Northeast Ohio,venture ... innovative,early-stage businesses and ideas, has announced an ... Cleveland-based company is,commercializing a patented, Federal Drug ... easily measure cervical length in,pregnant women, which ...
... focus of 48 NQF-endorsed measures, WASHINGTON, May ... hurdle in the United States, the National Quality,Forum ... on,measuring the performance of acute care hospitals, including ... care,of venous thromboembolism., "It has been difficult ...
... does not appear to help quality of life for ... (HealthDay News) -- Adding chemotherapy to other treatments being ... linked to asbestos exposure, does not appear to improve ... mesothelioma (MPM), which is usually fatal, is a cancer ...
... AARP commends Governor Paterson,s leadership in proposing prescription,drug ... 15 AARP strongly believes,New York has a ... proposals which address the undue influence that,pharmaceutical companies ... pocket books but the treatment they receive., ...
Other Medicine News:Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3Health News:CerviLenz Receives JumpStart Investment 2Health News:CerviLenz Receives JumpStart Investment 3Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 2Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 3Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 4Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 5Health News:Chemo for Mesothelioma Offers Limited Survival Benefits 2Health News:AARP Statement on Governor's Bill for Prescription Drug Marketing Reform and Transparency 2
(Date:12/14/2009)... 14 According to Millennium Research Group ... intelligence, increased use of safety devices for small-bore ... a key driver of the enteral feeding device ... new US and European Markets for Enteral ... giving set segment will experience the greatest impact ...
(Date:12/14/2009)... -- Caliper Life Sciences, Inc. (Nasdaq: ... and services for drug discovery and life sciences ... sale of Xenogen Biosciences Corporation ("XenBio"), a subsidiary ... Farms, Inc. for approximately $11 million. XenBio ... acquisition of Xenogen Corporation in 2006. Caliper ...
(Date:12/14/2009)... The U.S. Food and Drug Administration (FDA) ... Suspension for the treatment of schizophrenia in adults, ... ) announced today. ZYPREXA RELPREVV, a long-acting intramuscular ... to four weeks. ,, Different from both oral ... allow for stable concentrations of the active drug ...
Breaking Medicine Technology:Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 55775 1Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 55775 2In Case You Missed It Senator Bob Dole in The Washington Post 3A Starting Over on Health Care 55770 1In Case You Missed It Senator Bob Dole in The Washington Post 3A Starting Over on Health Care 55770 2Prostate Cancer Over Diagnosed 3A Study 55767 1Prostate Cancer Over Diagnosed 3A Study 55767 2Prostate Cancer Over Diagnosed 3A Study 55767 3
... March 7 NovaBay Pharmaceuticals, Inc. (NYSE ... first-in-class, novel, synthetic anti-infective products for the ... of bacterial, fungal, and viral infections without ... showing that NVC-422, the Company,s lead Aganocide(R) ...
... Poster Session at the 67th Annual Meeting of the ... Galderma Laboratories, L.P. today announced interim findings from a ... (R) (clobetasol propionate) Spray 0.05% followed by treatment ... an interim analysis of the data are to be ...
Other Medicine Technology:NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection 2NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection 3NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection 4Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis 2Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis 3Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis 4
Ideal for abdominal procedures...
... one-of-kind Expander Sizer™ is ... problem of achieving the ... Expander Sizer™ zipper system ... to post procedure swelling ...
For lipoplasty of trochanteric area, abdomen, thighs, hips, buttocks and flanks...
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Medicine Products: